This obvious confidence by the directors and CEO are unbelievably reassuring as they await the peer review release of the PII results details. They are doing it all the right way. We've known since we all have been hoarding shares, but now the public can be sure that confidence isn't just investors, it's the people who know all the pipeline and where it's going.
Insider Buying: Inovio Pharmaceuticals Director Purchases 40,600 Shares of Stock (INO)
Inovio Pharmaceuticals logoInovio Pharmaceuticals (NYSE:INO) Director Morton Collins acquired 40,600 shares of the stock in a transaction that occurred on Wednesday, August 20th. The shares were purchased at an average price of $9.74 per share, with a total value of $395,444.00. Following the completion of the purchase, the director now directly owns 173,066 shares of the company’s stock, valued at approximately $1,685,663. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link: http://www.sec.gov/Archives/edgar/data/1055726/000117911014013088/xslF345X01/edgar.xml
News 
Market Data 
Discover 
